In scientific journals, many casual studies report general increases in energy, stamina, mood, and mental sharpness
protocols are extrapolated from endocrine testing and experimental vascular-support studies
JAMA Intern Med (2018) 178:1098
According to FDA guidance, GLP-1 medications are not recommended for people who have: Pregnancy, because safety data are limited and pregnancy requires appropriate weight gain and nutrient storage A prior history of pancreatitis, due to a risk of triggering inflammation of the pancreas A history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2), a rare genetic condition linked to thyroid cancer in animal studies A clinician will review your medical history carefully to determine whether these medications are appropriate for you
That's an objective way to frame this Kind of maybe clumsy way to say it too
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ozempic specifically for glycaemic control in adults with type 2 diabetes, either as monotherapy or in combination with other glucose-lowering medicines